Free Trial
NASDAQ:ELAB

PMGC (ELAB) Stock Price, News & Analysis

PMGC logo
$4.86 +0.20 (+4.18%)
As of 03:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About PMGC Stock (NASDAQ:ELAB)

Key Stats

Today's Range
$4.60
$4.99
50-Day Range
$1.62
$9.00
52-Week Range
$4.57
$1,837.50
Volume
108,438 shs
Average Volume
428,590 shs
Market Capitalization
$7.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PMGC Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

ELAB MarketRank™: 

PMGC scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for PMGC.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PMGC is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    PMGC has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.28% of the outstanding shares of PMGC have been sold short.
  • Short Interest Ratio / Days to Cover

    PMGC has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PMGC has recently decreased by 13.34%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    PMGC does not currently pay a dividend.

  • Dividend Growth

    PMGC does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.28% of the outstanding shares of PMGC have been sold short.
  • Short Interest Ratio / Days to Cover

    PMGC has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PMGC has recently decreased by 13.34%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    PMGC has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.92 average news sentiment score of Multi-Sector Conglomerates companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for PMGC this week, compared to 2 articles on an average week.
  • Search Interest

    4 people have searched for ELAB on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PMGC insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.24% of the stock of PMGC is held by insiders.

  • Percentage Held by Institutions

    Only 22.22% of the stock of PMGC is held by institutions.

  • Read more about PMGC's insider trading history.
Receive ELAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PMGC and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELAB Stock News Headlines

Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.tc pixel
Best Penny Stocks To Watch Now - August 23rd
Small Cap Stocks To Follow Now - August 22nd
See More Headlines

ELAB Stock Analysis - Frequently Asked Questions

PMGC's stock was trading at $56.1050 at the beginning of the year. Since then, ELAB stock has decreased by 91.4% and is now trading at $4.82.

PMGC Holdings Inc. (NASDAQ:ELAB) posted its earnings results on Wednesday, May, 14th. The company reported ($10.15) earnings per share for the quarter.

Shares of PMGC reverse split before market open on Tuesday, September 2nd 2025.The 2-7 reverse split was announced on Thursday, August 28th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 29th 2025. An investor that had 100 shares of stock prior to the reverse split would have 29 shares after the split.

PMGC (ELAB) raised $6 million in an initial public offering on Tuesday, November 21st 2023. The company issued 1,500,000 shares at $4.00 per share. Univest Securities acted as the underwriter for the IPO.

Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PMGC investors own include BIOLASE (BIOL), CDT Equity (CDT), Cyclacel Pharmaceuticals (CYCC), Dare Bioscience (DARE), TRACON Pharmaceuticals (TCON), Tempest Therapeutics (TPST) and 22nd Century Group (XXII).

Company Calendar

Last Earnings
5/14/2025
Today
9/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
DIVERSIFIED OPS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ELAB
Previous Symbol
NASDAQ:ELAB
CIK
1840563
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($433.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.25 million
Net Margins
N/A
Pretax Margin
-508,006.59%
Return on Equity
-62.73%
Return on Assets
-52.83%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.40
Quick Ratio
22.40

Sales & Book Value

Annual Sales
$1.71 million
Price / Sales
4.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.09 per share
Price / Book
0.77

Miscellaneous

Outstanding Shares
1,480,000
Free Float
1,481,000
Market Cap
$6.90 million
Optionable
N/A
Beta
0.17
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ELAB) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners